How I do it: How to care for the patient with methamphetamine-associated PAH

By afschroeder • March 13, 2026

Kolaitis NA, Barnett CF, Chin KM, Clapham K, Incze MA, Kennedy AJ, Kingrey JF, Matusov Y, Melendres-Groves L, Rischard FP, Simon MA. How I do it: How to care for the patient with methamphetamine-associated PAH. Chest. 2026 Mar 10:S0012-3692(26)00290-4. doi: 10.1016/j.chest.2026.02.016. Epub ahead of print. PMID: 41819484.

Tags: Amphetamine, Cedars Sinai DoM, Meth, Meth-APAH, Methamphetamine, PAH, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial

Baden LR, Shah NS, Liu STH, Cohen J, Moy J, Kumar A, McComsey GA, Chen P, Floris-Moore M, Singer NG, Fernandez I, Slandzicki AJ, Wiley[...]

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S,[...]

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Hegde SM, Wang X, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, de Barros Correia[...]